These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26016451)

  • 1. Oxidative stress and paraoxonase 1 status in acute ischemic stroke patients.
    Kotur-Stevuljevic J; Bogavac-Stanojevic N; Jelic-Ivanovic Z; Stefanovic A; Gojkovic T; Joksic J; Sopic M; Gulan B; Janac J; Milosevic S
    Atherosclerosis; 2015 Jul; 241(1):192-8. PubMed ID: 26016451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients.
    Ivanišević J; Kotur-Stevuljević J; Stefanović A; Spasić S; Vučinić Mihailović V; Videnović Ivanov J; Jelić-Ivanović Z
    Eur J Clin Invest; 2016 May; 46(5):418-24. PubMed ID: 26919159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Paraoxonase 1 Activity and Oxidative/Antioxidative Stress Markers in Patients with Acute Cerebral Infarction.
    Zhu H; Zhao T; Liu J
    Clin Lab; 2018 Jun; 64(6):1049-1053. PubMed ID: 29945323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
    Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
    Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
    Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
    Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PON1 status is influenced by oxidative stress and inflammation in coronary heart disease patients.
    Kotur-Stevuljevic J; Spasic S; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Stefanovic A; Vujovic A; Memon L; Kalimanovska-Ostric D
    Clin Biochem; 2008 Sep; 41(13):1067-73. PubMed ID: 18634772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary function, oxidative stress and inflammatory markers in severe COPD exacerbation.
    Stanojkovic I; Kotur-Stevuljevic J; Milenkovic B; Spasic S; Vujic T; Stefanovic A; Llic A; Ivanisevic J
    Respir Med; 2011 Oct; 105 Suppl 1():S31-7. PubMed ID: 22015083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased paraoxonase-1 activity is a risk factor for ischemic stroke in Koreans.
    Kim NS; Kang K; Cha MH; Kang BJ; Moon J; Kang BK; Yu BC; Kim YS; Choi SM; Bang OS
    Biochem Biophys Res Commun; 2007 Dec; 364(1):157-62. PubMed ID: 17936248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of oxidative stress and metabolic adaptation on PON1 activity and MDA level in transition dairy cows.
    Turk R; Juretić D; Geres D; Svetina A; Turk N; Flegar-Mestrić Z
    Anim Reprod Sci; 2008 Oct; 108(1-2):98-106. PubMed ID: 17850995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The usefulness of advanced lipid and oxidative stress testing for diagnosis and management of low HDL-cholesterol phenotype: A case report.
    Kuburovic V; Vekic J; Zeljkovic A; Carrie A; Kotur-Stevuljevic J; Bojanin D; Kosutic J; Spasojevic-Kalimanovska V; Miljkovic M; Kuburovic N; Couvert P
    Clin Biochem; 2017 Dec; 50(18):1323-1325. PubMed ID: 28648695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes.
    Kabaroglu C; Mutaf I; Boydak B; Ozmen D; Habif S; Erdener D; Parildar Z; Bayindir O
    Acta Cardiol; 2004 Dec; 59(6):606-11. PubMed ID: 15636443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between selected oxidative stress markers and lipid risk factors for cardiovascular disease in middle-aged adults and its possible clinical relevance.
    Viktorinova A; Svitekova K; Stecova A; Krizko M
    Clin Biochem; 2016 Aug; 49(12):868-72. PubMed ID: 27240017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes.
    Viktorinova A; Jurkovicova I; Fabryova L; Kinova S; Koren M; Stecova A; Svitekova K
    Diabetes Res Clin Pract; 2018 Jun; 140():174-182. PubMed ID: 29626583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
    Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
    Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia.
    Agouridis AP; Tsimihodimos V; Filippatos TD; Dimitriou AA; Tellis CC; Elisaf MS; Mikhailidis DP; Tselepis AD
    Expert Opin Pharmacother; 2011 Dec; 12(17):2605-11. PubMed ID: 21714585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower levels of high-density lipoprotein cholesterol on admission and a recurrence of ischemic stroke: a 12-month follow-up of the Fukuoka Stroke Registry.
    Kuwashiro T; Sugimori H; Kamouchi M; Ago T; Kitazono T; Iida M
    J Stroke Cerebrovasc Dis; 2012 Oct; 21(7):561-8. PubMed ID: 21376631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PON1, a new biomarker of cardiovascular disease, is low in patients with systemic vasculitis.
    Quéméneur T; Martin-Nizard F; Kandoussi A; Kyndt X; Vanhille P; Hachulla E; Hatron PY; Fruchart JC; Duriez P; Lambert M
    Semin Arthritis Rheum; 2007 Dec; 37(3):149-55. PubMed ID: 17512573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
    Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
    Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.